1
Objective. Antibodies to cyclic citrullinated peptides (anti-CCP) in rheumatoid arthritis (RA) can express the inherently autoreactive gene V H 4-34, detected using the rat monoclonal antibody 9G4. Patients with the polyarticular subtype of juvenile idiopathic arthritis (JIA) share some but not all of the features of adult patients with RA. This study was undertaken to compare serologic findings for rheumatoid factor (RF), anti-CCP, and 9G4-expressing anti-CCP in a large JIA cohort with a cohort of adult RA patients.
Methods. Serum from 88 patients with polyarticular JIA, 29 patients with enthesitis-related arthritis, 38 patients with extended oligoarthritis, 31 adolescent controls, 35 patients with RA, and 30 adult controls were tested for RF, for IgG, IgA, and IgM anti-CCP, and for 9G4-expressing anti-CCP by enzyme-linked immunosorbent assay. Total serum 9G4-positive IgM was also measured.
Results. Of 65 patients with RF-negative polyarticular JIA, 4 (6.2%) were IgG anti-CCP positive. Sera from 20 of 23 patients with RF-positive polyarticular JIA (87.0%), 24 of 35 patients with RA (68.6%), and 1 patient with extended oligoarthritis contained IgG anti-CCP. IgA and IgM anti-CCP levels were lower in the adolescent group (P < 0.01). Levels of 9G4-expressing anti-CCP were higher in patients with RF-positive polyarticular JIA than in those with RF-negative polyarticular JIA (P < 0.0001). Median levels of 9G4-expressing anti-CCP in patients with RF-positive polyarticular JIA and those with RA did not differ. Expression of 9G4 on serum total IgM was greater in patients with RF-positive polyarticular JIA than other adolescent groups (P < 0.01), but similar to adult RF-positive RA.
Conclusion. In healthy individuals, 9G4-positive B cells comprise 5-10% of the peripheral blood pool but serum immunoglobulins utilizing V H 4-34 are disproportionately low. The idiotope recognized by 9G4 was detected on anti-CCP antibodies in >80% of patients with RFpositive polyarticular JIA. V H 4-34 usage by anti-CCP in both JIA and RA patients suggest elicitation of these autoantibodies through shared pathogenic B cell selection processes.
Juvenile idiopathic arthritis (JIA), as defined by the updated International League of Associations for Rheumatology (ILAR) classification criteria (1) , is an umbrella term encompassing different subtypes of arthritis with onset in those age ,16 years. Rheumatoid factor (RF)-positive polyarticular JIA is one of the more severe subtypes of JIA. It is associated with older onset (being more frequently seen in adolescents) and more disability compared to other subtypes, and more frequently progresses into adulthood, requiring continuing treatment (2) . Clinically, of all of the subtypes of JIA, RF-positive polyarticular JIA most closely resembles that of adult-onset rheumatoid arthritis (RA). However, there are subtle differences in the clinical pattern of disease in addition to the difference in the age at onset. Young people with RF-positive polyarticular JIA tend to have more frequent involvement of the temporomandibular joints and ankles. This is captured by the Juvenile Arthritis Disease Activity Score (3) but excluded from the Disease Activity Score in 28 joints (4), which is used in routine practice in patients with RA (5). Hence, it is uncertain to what extent RF-positive polyarticular JIA represents early-onset RA, or whether it represents a type of inflammatory arthritis of childhood onset that has pathogenic pathways that are distinct from those of adult-onset RA.
The consensus now is that RF-positive polyarticular JIA is associated with a high frequency of IgG class antibodies to citrullinated proteins, as measured in the clinic using commercial cyclic citrullinated peptides (CCPs) as the substrate. The frequency of anti-CCP positivity in RFpositive polyarticular JIA has been shown to be comparable to that seen in adult seropositive RA (6) (7) (8) (9) (10) (11) . However, most of those studies were of relatively small numbers of patients, most did not include separate diagnostic cohorts within the global categorization of "JIA," and very few compared their findings with those in local adult cohorts of RA. Importantly, previous studies have not investigated upstream pathways of autoantibody production in order to better understand the pathogenesis of RF-positive polyarticular JIA and to what extent this overlaps with RA. One method to investigate this research question is to define the genes that encode for anti-CCP antibody expression and determine whether they are shared by RF-positive polyarticular JIA and seropositive RA.
Although the variable regions of the heavy chain of immunoglobulins are encoded by a total of 123 heavy-chain variable region (Ig V H ) genes, with nearly half expressed as V H segments, there is a degree of skewing toward the usage of certain V H genes in autoimmunity and B cell malignancy. The use of particular genes encoding Ig V H has been associated with the development of autoantibodies (12, 13) , with those encoded by V H 4-34 being the prototype in autoimmune diseases (14, 15) . Immunoglobulins derived from this gene, even in a germline configuration, are inherently autoreactive and can recognize a number of self antigens in the absence of antigen-driven selection. The rat monoclonal antibody 9G4 binds a unique conformational epitope confined largely within framework region 1 of the V H region of immunoglobulins derived from the V H 4-34 gene. (16, 17) .
In autoimmunity, however, V H 4-34-derived sequences are overrepresented in autoantibodies. V H 4-34 usage is, for example, obligatory for most cold agglutinins (18) , utilized by some IgG anti-double-stranded DNA antibodies in serum, and also found deposited in renal biopsy specimens from patients with systemic lupus erythematosus (SLE) (19) and used by antimyeloperoxidase antibodies in systemic vasculitis (20) . More recently, we have described 9G4-positive autoantibodies specific for CCP in patients with early RA (,6 weeks of joint symptoms) and those with established RA (21) . Investigating the isotype distribution and presence of the 9G4 idiotope on anti-CCP antibodies in RF-positive polyarticular JIA and comparing this to a local seropositive adult RA population may therefore further our understanding of potential common pathways for autoreactive B cell selection in RF-positive polyarticular JIA.
PATIENTS AND METHODS
Patients. at any time before sampling. In the juvenile cohorts, approximately two-thirds of the patients with polyarticular JIA (53 of 88) and those with extended oligoarticular JIA (22 of 38) were receiving methotrexate (MTX), with equal proportions in each group (36%) receiving biologic therapies (tumor necrosis factor [TNF] inhibition). Two-thirds of the patients with ERA (19 of 29) were receiving MTX, 6 were receiving additional or alternative diseasemodifying antirheumatic drugs (DMARDs) (sulfasalazine [SSZ] or hydroxychloroquine [HCQ]), and 17% (n 5 5) were receiving biologic agents. These were mainly TNF inhibitors, with 1 patient receiving abatacept and 2 patients receiving tocilizumab. Of 35 adult RA patients, 2 were not receiving treatment, 33 were receiving DMARDs, usually MTX (n 5 18), SSZ (n 5 8), and HCQ (n 5 7), 13 were receiving biologic agents (all anti-TNF), and 9 were receiving oral prednisolone (all ,20 mg/day).
Sera were obtained from collections within The Centre for Rheumatology, and the Arthritis Research UK Centre for Adolescent Rheumatology, University College London and selected on the basis that they fulfilled the ILAR classification criteria for JIA (1) or the American College of Rheumatology and European League Against Rheumatism (EULAR) classification criteria for RA (22) . All subjects donated blood after informed consent, and the study was approved by the local ethics committee (REC 11/LO/ 0330 [adolescent cohorts] and REC 08/H0714/18 [adult cohorts]).
Measurement of anti-CCP antibodies. Anti-CCP antibodies in patient and control sera diluted 1:200 were measured using a commercial 96-well enzyme-linked immunosorbent assay (ELISA), using plates precoated with second-generation citrullinated peptides (CCP2) (FCCP600; Axis-Shield Diagnostics). IgG anti-CCP were measured according to kit protocol with a cutoff for positivity of 5 units/ml.
Horseradish peroxidase (HRP)-conjugated sheep antihuman IgA or IgM (The Binding Site) was used to detect anti-CCP antibodies of the given isotype using the same ELISA plates as for IgG anti-CCP.
Levels of IgA anti-CCP antibodies were calculated with reference to an in-house standard (representing 100 arbitrary units [AU]) included on each ELISA test plate as well as negative controls. Results were expressed as a proportion of the positive control following subtraction of background binding of HRP conjugate and normalization between different ELISA plates. IgA anti-CCP are rarely observed in healthy control sera (21) and cutoff was therefore based on calculations using the mean 1 3SD of binding by 60 sera from healthy controls across all age groups (giving a value of 11 AU/ml) (21) . In contrast, IgM class antibodies to CCP are commonly observed in sera from healthy adult controls, and since we had no reference for a cutoff level to cover both adolescent and adult IgM anti-CCP levels in samples, results are expressed as optical density (OD) (31,000) given by serum samples following subtraction of background binding of conjugate alone to CCP-coated wells.
Determination of IgM-RF status. For JIA patients, IgM-RF status was obtained from historical clinical data from standard laboratory tests (RA particle agglutination assay). An in-house protocol was used to determine RF status in healthy adult and adolescent controls using affinity-purified rabbit IgG (Sigma-Aldrich) as the substrate. Briefly, binding of sera (diluted 1:200) to affinity-purified rabbit IgG-coated wells and to uncoated wells was measured using goat anti-human IgM-HRP conjugate (The Binding Site). After subtracting background binding (to uncoated wells), arbitrary units of binding were calculated by reference to a standard curve constructed from a commercial source (Cambridge Life Sciences) with values of .23 AU/ml considered positive.
Detection of 9G4 expression on anti-CCP and on serum total IgM. For detection of 9G4 expression on antibodies to CCP, sera (diluted 1:50 in RD6Q diluent; R&D Systems) were added to antigen-coated wells of ELISA plates. Following incubation, the 9G4 reagent (IGM Bioscience) was added at a concentration of 2 mg/ml to one side of the plate, and the duplicate serum-incubated wells received diluent buffer containing equivalent affinity-purified normal rat IgG1 (SigmaAldrich) instead of 9G4. An affinity-purified HRP-conjugated goat anti-rat IgG reagent (Amersham) was used to detect 9G4 recognition of CCP2-binding antibodies. Results were calculated and presented as OD 3 100 at 450 nm following the subtraction of any background binding in wells in the absence of the 9G4 reagent. To assess 9G4 binding to total serum IgM, sera diluted 1:250 were added to each side of ELISA plates that were either left uncoated or coated with 2 mg/ml murine Fab 2 anti-human IgM (eBioscience). Following blocking with 1% bovine serum albumin, the rat 9G4 reagent was added at 2 mg/ml. Subsequently, goat anti-rat HRP conjugate (Abcam) was used for detection, and tetramethylbenzidine was used for development. Background binding to the uncoated side of the plates was subtracted, and results were expressed as the OD at 450 nm.
Statistical analysis. GraphPad Prism was used for all statistical analyses. Nonparametric statistics for populations not following a normal distribution (Mann-Whitney U test) were used to compare groups. For determination of relationships between variables, linear regression (Pearson's correlation) was used. P values less than 0.01 were considered significant.
RESULTS
Elevated levels of IgG anti-CCP in patients with RF-positive polyarticular JIA and patients with RF-positive RA. Table 2 summarizes the RF status and frequency of class-switched anti-CCP antibodies in the adult RA, JIA, extended oligoarthritis, and ERA patient groups. In the adult RA patients, 20 of 26 RF-positive serum samples (77%) also contained IgG anti-CCP. Of 88 patients diagnosed as having polyarticular JIA, 65 were RF negative. The differences in IgA anti-CCP levels were mirrored when sera from healthy adolescents (median 3.4 AU/ ml [IQR 3.6-3.9]) and sera from adults (median 6.3 AU/ml [IQR 5.2-7.7]) were compared (P , 0.0001), but the levels in most samples from adolescents were well below the cutoff for positivity. Healthy adults also had significantly Although healthy adult controls and patients with RA were not matched for age, there was no correlation between levels of any isotype of anti-CCP with disease duration or age within either the juvenile or adult cohorts (data not shown).
Anti One explanation for the detection of 9G4 expression on antibodies to CCP in patients with RF-positive polyarticular JIA is that there is a general expansion of usage of this V H gene in adolescents. Since serum IgM contains virtually all 9G4-expressing immunoglobulin Figure 2B ). Expression of 9G4 on serum total IgM was significantly higher in patients with RF-positive polyarticular JIA than in healthy adolescent controls (P , 0.001), but similar to that found in RFpositive adult RA ( Figure 2B ). However, only 5 of 19 samples exceeded the upper limit of the range in sera from healthy controls age ,23 years ( Figure 2B) , and there was no correlation between 9G4-expressing anti-CCP and 9G4 on serum total IgM as determined by capture ELISA ( Figure 3A ) (Pearson's correlation coefficient r 2 5 0.11; P 5 0.15), suggesting that despite a possible increase in 9G4 IgM, 9G4-positive B cells committed to anti-CCP antibody production may have undergone differentiation by a different pathway of activation. There was no correlation between 9G4-expressing anti-CCP and 9G4 binding to serum total IgM in adult RA patients ( Figure 3B ).
With respect to the Ig class distribution of 9G4-expressing anti-CCP antibodies in adult RA patients, the results of our previous experiments suggested that 9G4 expression was associated with IgM anti-CCP but that a small proportion may also be of IgG class (21) . We have yet to undertake similar experiments using adolescent patient samples, but analyzed possible correlations between the levels of the different classes of anti-CCP in adult RA and RF-positive polyarticular JIA and 9G4-expressing anti-CCP, using linear regression analysis (Figure 4) . Interestingly, differences were found between patients with polyarticular JIA and adult RA patients. Binding of 9G4 to anti-CCP antibodies was strongly correlated with levels of IgM anti-CCP in adolescent but not adult patients (Figures 4A and D) . IgG anti-CCP antibody levels, however, were similarly correlated, albeit weakly, with 9G4-expressing anti-CCP in both diseases ( Figures  4B and E) . The strongest correlation was between IgA anti-CCP and 9G4-expressing anti-CCP in polyarticular 
DISCUSSION
Class-switched (IgG) anti-CCP antibodies, while rare in JIA patients overall, were found to occur predominantly in the subset of patients with polyarticular JIA who also tested positive for RF, supporting previous findings in smaller cohorts (6) (7) (8) (9) (10) (11) . We also confirmed that the IgG anti-CCP antibody profile of patients with RF-positive polyarticular JIA was significantly distinct from both ageand sex-matched healthy controls and patients with other subtypes of JIA. Only 3.1% (5 of 163) of all disease controls or age-and sex-matched healthy controls tested positive for IgG anti-CCP antibodies. IgG anti-CCP isotype serology in serum samples from RF-positive adolescent patients with polyarticular JIA was compared directly with that in serum samples from RF-positive adults with RA. Although the prevalence of anti-CCP antibodies in RA has been widely studied, for the purposes of this investigation we included a random sample of our own adult cohort, to eliminate discrepancies in methodology or cutoffs for positivity. No significant difference was found between the levels of IgG anti-CCP antibodies in RFpositive polyarticular JIA and RF-positive RA. This suggests that the IgG anti-CCP antibody phenotypes of the two diseases are similar, consistent with the parallels seen in other diagnostic criteria between these two conditions.
IgG anti-CCP antibodies are routinely tested upon clinician's request, but are not included in the current diagnostic criteria for RF-positive polyarticular JIA (1) . The confirmation of the specificity of IgG anti-CCP antibodies for RF-positive polyarticular JIA, in contrast to both healthy controls and JIA disease controls, suggests that IgG anti-CCP levels could also prove a worthwhile formal addition to existing criteria for RF-positive polyarticular JIA.
Levels of IgA anti-CCP antibodies were significantly higher in patients with RF-positive polyarticular JIA than in all control groups, but values were very low, with the median and the value for most samples (14 of 19 [74%] ) within the normal range in our assay. Adult RA patients also had significantly higher levels of IgM anti-CCP compared with the adolescent patients with RFpositive polyarticular JIA, despite their comparable IgG anti-CCP levels. Most patients in all of the disease groups were receiving DMARDs, and many were also receiving biologic agents, so it was difficult to attribute any significant effects of treatment on differences in autoantibody isotype between patient groups. This presents the interesting question as to whether anti-CCP antibodies follow the same pathway of class-switching that is seen in adult RA patients. The lower IgA anti-CCP antibody levels in JIA may also indicate that the class switch to IgG anti-CCP precedes the possible accumulation of switched B cells of IgA isotype in juvenile versus adult patients. As we and others have shown, IgM autoantibodies can persist at high levels alongside class-switched species and therefore do not follow the patterns that would be expected in a normal humoral response to immunization or some infectious insults (23) .
In RA, it is well established that the presence of anti-CCP antibodies can predate clinical symptoms by up to 10 years (24) (25) (26) . If the case is put forward that RFpositive polyarticular JIA does represent very early onset RA, following up patients with RF-positive polyarticular JIA into adulthood should show that they develop the same profile as patients with RF-positive RA. Although it would be very difficult to ascertain whether anti-CCP positivity antedates symptoms in children with RF-positive polyarticular JIA, the question arises as to why these patients develop symptoms at a much younger age, while adult RA patients may be anti-CCP positive for many years before the onset of disease. The time at which treatment with biologic agents is initiated can influence the duration and severity of symptoms, as well as a patient's chances of remission (27) . Both the Trial of Early Aggressive Therapy (TREAT) (28) and the Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (ACUTE-JIA) study (29) demonstrated that in polyarticular JIA, early and aggressive treatment induced significantly higher clinical remission rates and significantly reduced joint erosion and narrowing (30, 31) . Early detection of autoimmunity may therefore aid in exploiting such a window of opportunity in patients with polyarticular JIA.
It has been postulated that what begins as an abnormal immune response, with anti-CCP positivity, requires a "second event" in order to convert this response into active disease (32) . Indeed, the number of citrullinated epitopes recognized by patient antibodies was shown to increase over time, and anti-CCP levels to markedly increase 2-4 years prior to an RA diagnosis, but then to plateau after onset, suggestive of a second stage in disease development (26) . We also found that few new epitope specificities arose after B cell depletion with rituximab in adult RA patients (33) . In future studies, it could prove interesting to explore whether this process is accelerated in RF-positive polyarticular JIA, and if so, what drives this occurrence.
In addition to defining antibodies by the antigens that they detect, immunoglobulins may also be distinguished by hypervariable region structures known as idiotypes. The idiotope recognized by the 9G4 rat monoclonal antibody forms a hydrophobic patch that binds to Nacetyllactosamine residues that are present on a number of self and microbial glycoproteins and glycolipids (34, 35) . The ability to recognize N-acetyllactosamine is potentially advantageous in assisting the clearance of damaged, apoptotic, or neoplastic cells but may also risk autoimmunity if excessive mutation in the antigencombining site, located predominantly within the complementarity-determining regions, confers additional binding to a self-specificity.
If a particular idiotype is found in different patients, but on a particular group of antibodies (e.g., anti-CCP), this is a strong indication that the unrelated individuals share usage of the same immunoglobulin-encoding gene (19) . The V H 4-34 gene, which is strongly associated with autoimmunity (12) , has been demonstrated to be utilized by anti-CCP antibodies in patients with (adult-onset) RA (21) . This was seen both in patients with early RA and in those with established RA, but not in those with early polyarthritis not evolving into RA. It also suggests a notable restriction in V H gene usage that biases the development of their immunoglobulin repertoire, which may be instrumental in the production of autoantibodies to citrullinated proteins (12) . In this study we have confirmed that this inherently autoreactive idiotope is also found on anti-CCP antibodies in patients with RF-positive polyarticular JIA.
In conclusion, this study has demonstrated the novel finding that adolescent patients with RF-positive polyarticular JIA have an anti-CCP antibody phenotype that is distinct from that of patients with other clinical subtypes of JIA and age-and sex-matched healthy controls. Patients with RF-positive polyarticular JIA have levels of IgG anti-CCP comparable to those in RF-positive adult patients, and both express the same inherently autoreactive 9G4 idiotype. However, it was found that the adult group had significantly higher levels of IgA and IgM antiCCPs than the adolescent group, suggesting that further investigation is needed to fully elucidate the extent to which these two conditions may be seen as one.
